Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database.

[1]  A. Partin,et al.  Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findings. , 1999, Urology.

[2]  Mc,et al.  Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's , 1998 .

[3]  J. Moul,et al.  The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases. , 1998, The Journal of urology.

[4]  J. Moul,et al.  Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer. , 1998, The Journal of urology.

[5]  P. Walsh.  Screening for prostate cancer. American College of Physicians. , 1997, The Journal of urology.

[6]  J. Moul,et al.  Age-specific reference ranges for serum prostate-specific antigen in black men. , 1996, The New England journal of medicine.

[7]  J. Moul,et al.  Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. , 1996, The Journal of urology.

[8]  A. Partin,et al.  Radical prostatectomy in men less than 50 years old. , 1995, Urologic oncology.

[9]  Zuo-Feng Zhang,et al.  Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients , 1994, Cancer.

[10]  F. Mostofi,et al.  Clinically detected carcinoma of the prostate treated by radical prostatectomy in a 29-year-old man. , 1994, The Journal of urology.

[11]  P. Scardino,et al.  The new american joint committee on cancer and international union against cancer tnm classification of prostate cancer , 1994, Cancer.

[12]  W. Catalona,et al.  Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.

[13]  A. Benghiat,et al.  Natural history and prognosis of prostate carcinoma in adolescents and men under 35 years of age. , 1992, British journal of urology.

[14]  M. Benson,et al.  Prostate cancer in men less than 45 years old: influence of stage, grade and therapy. , 1987, The Journal of urology.

[15]  G. Harrison.  The prognosis of prostatic cancer in the younger man. , 1983, British journal of urology.

[16]  G. Murphy,et al.  Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey. , 1982, Urology.

[17]  J. Cochran,et al.  A private practice experience with adenocarcinoma of the prostate in men less than 50 years old. , 1981, The Journal of urology.

[18]  N. Breslow,et al.  Statistical methods for censored survival data. , 1979, Environmental health perspectives.

[19]  I. Silber,et al.  Adenocarcinoma of the prostate in men less than 56 years old: a study of 65 cases. , 1971, The Journal of urology.

[20]  F. Mostofi,et al.  Cancer of the prostate in men less than 50 years old: an analysis of 51 cases. , 1969, The Journal of urology.

[21]  D. Culp,et al.  CLINICAL ADENOCARCINOMA OF THE PROSTATE IN PATIENTS UNDER 50 YEARS OF AGE. , 1965, The Journal of urology.

[22]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[23]  A. Partin,et al.  Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. , 1999, Urology.

[24]  O. Khanna,et al.  Carcinoma of prostate in men aged fifty and under: therapeutic options. , 1992, Urology.

[25]  D. Johnson,et al.  Prostatic adenocarcinoma occurring in men under 50 years of age , 1972, Journal of surgical oncology.

[26]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .